Zoetis | ZTS - Current Liabilities

Stock Price
115.62
Daily Change
0.16 0.14%
Monthly
-7.92%
Yearly
-28.30%
Q1 Forecast
112.13

Zoetis reported $2.24B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Align Technology USD 1.92B 46.45M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Coherus Biosciences USD 140.39M 231.91M Dec/2025
Dentsply International USD 1.34B 62M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Henry Schein USD 3.23B 79M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Illumina USD 1.59B 377M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Neogen USD 147.05M 850K Sep/2025
Pacira USD 120.59M 13.51M Dec/2025
Perrigo USD 1.01B 132.4M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
Quest Diagnostics USD 2.28B 144M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Sanofi EUR 28.35B 9.32B Dec/2025
Zoetis USD 2.24B 428M Dec/2025